A new type 2 diabetes pill known as Tradjenta from Boehringer, a German company, and Indianapolis-based Eli Lilly & Co. has been approved by the Food and Drug Administration.
134512
New type 2 diabetes pill, Tradjenta, approved
92290
TSA agents confiscate pregnant woman's insulin
91515
Pfizer gets the approval
172167
Roche discloses the results of first phase III clinical study using taspoglutide
122574
Drug companies increasingly use medical science liaisons
129407
E-Therapeutics granted US patent for key process
83928
FDA approves Egrifta for treatment of lipodystrophy in people with HIV
10934
FDA lifts partial hold on Icagen drug;
32474
GlaxoSmithKline to acquire Sirtris Pharmaceuticals
140704
Amgen licenses molecule for the treatment of chronic and neuropathic pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc.
94684
Use of statins increases the risk of developing type 2 diabetes
157784
BioElectronics announces revolutionary device for treatment of
95584
Wockhardt gains on launching generic of Wellbutrin SR in US
96078
US drug regulator approves swine flu vaccine
151918
Human stem cell transplants successfully reversed diabetes in mice
34605
Eli Lilly acquires SGX Pharmaceuticals
148888
Medelita announces new European distributor--